Annual EBIT
-$41.76 M
-$5.23 M-14.32%
December 31, 2023
Summary
- As of February 7, 2025, LRMR annual earnings before interest & taxes is -$41.76 million, with the most recent change of -$5.23 million (-14.32%) on December 31, 2023.
- During the last 3 years, LRMR annual EBIT has risen by +$1.05 million (+2.44%).
- LRMR annual EBIT is now -79.88% below its all-time high of -$23.21 million, reached on December 31, 2019.
Performance
LRMR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.26 M
+$6.33 M+25.75%
September 30, 2024
Summary
- As of February 7, 2025, LRMR quarterly earnings before interest & taxes is -$18.26 million, with the most recent change of +$6.33 million (+25.75%) on September 30, 2024.
- Over the past year, LRMR quarterly EBIT has increased by +$6.33 million (+25.75%).
- LRMR quarterly EBIT is now -393.09% below its all-time high of -$3.70 million, reached on June 30, 2019.
Performance
LRMR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$73.76 M
-$7.92 M-12.04%
September 30, 2024
Summary
- As of February 7, 2025, LRMR TTM earnings before interest & taxes is -$73.76 million, with the most recent change of -$7.92 million (-12.04%) on September 30, 2024.
- Over the past year, LRMR TTM EBIT has dropped by -$7.92 million (-12.04%).
- LRMR TTM EBIT is now -1891.33% below its all-time high of -$3.70 million, reached on June 30, 2019.
Performance
LRMR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LRMR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | +25.8% | -12.0% |
| 3 y3 years | +2.4% | +25.8% | -12.0% |
| 5 y5 years | -79.9% | +25.8% | -12.0% |
LRMR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.3% | +17.3% | -139.2% | +25.8% | -109.7% | at low |
| 5 y | 5-year | -79.9% | +17.3% | -196.6% | +25.8% | -298.9% | at low |
| alltime | all time | -79.9% | +17.3% | -393.1% | +25.8% | -1891.3% | at low |
Larimar Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.26 M(-25.8%) | -$73.76 M(+12.0%) |
| Jun 2024 | - | -$24.60 M(+47.0%) | -$65.83 M(+29.5%) |
| Mar 2024 | - | -$16.73 M(+18.2%) | -$50.85 M(+21.8%) |
| Dec 2023 | -$41.76 M(+14.3%) | -$14.16 M(+37.0%) | -$41.76 M(+9.8%) |
| Sep 2023 | - | -$10.34 M(+7.5%) | -$38.03 M(+5.0%) |
| Jun 2023 | - | -$9.62 M(+26.0%) | -$36.21 M(+2.6%) |
| Mar 2023 | - | -$7.64 M(-26.8%) | -$35.28 M(-3.4%) |
| Dec 2022 | -$36.53 M(-27.6%) | -$10.44 M(+22.6%) | -$36.53 M(+3.8%) |
| Sep 2022 | - | -$8.51 M(-2.0%) | -$35.17 M(-18.9%) |
| Jun 2022 | - | -$8.69 M(-2.3%) | -$43.39 M(-8.2%) |
| Mar 2022 | - | -$8.89 M(-2.2%) | -$47.25 M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$50.47 M(+17.9%) | -$9.09 M(-45.7%) | -$50.47 M(-9.5%) |
| Sep 2021 | - | -$16.73 M(+33.4%) | -$55.77 M(+13.0%) |
| Jun 2021 | - | -$12.54 M(+3.6%) | -$49.38 M(+2.4%) |
| Mar 2021 | - | -$12.11 M(-15.9%) | -$48.24 M(+12.7%) |
| Dec 2020 | -$42.80 M(+84.4%) | -$14.40 M(+39.3%) | -$42.80 M(+23.8%) |
| Sep 2020 | - | -$10.34 M(-9.3%) | -$34.57 M(+5.2%) |
| Jun 2020 | - | -$11.40 M(+70.8%) | -$32.86 M(+30.6%) |
| Mar 2020 | - | -$6.67 M(+8.4%) | -$25.16 M(+36.1%) |
| Dec 2019 | -$23.21 M | -$6.16 M(-28.6%) | -$18.49 M(+49.9%) |
| Sep 2019 | - | -$8.63 M(+132.9%) | -$12.33 M(+232.9%) |
| Jun 2019 | - | -$3.70 M | -$3.70 M |
FAQ
- What is Larimar Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Larimar Therapeutics?
- What is Larimar Therapeutics annual EBIT year-on-year change?
- What is Larimar Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly EBIT year-on-year change?
- What is Larimar Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Larimar Therapeutics?
- What is Larimar Therapeutics TTM EBIT year-on-year change?
What is Larimar Therapeutics annual earnings before interest & taxes?
The current annual EBIT of LRMR is -$41.76 M
What is the all time high annual EBIT for Larimar Therapeutics?
Larimar Therapeutics all-time high annual earnings before interest & taxes is -$23.21 M
What is Larimar Therapeutics annual EBIT year-on-year change?
Over the past year, LRMR annual earnings before interest & taxes has changed by -$5.23 M (-14.32%)
What is Larimar Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of LRMR is -$18.26 M
What is the all time high quarterly EBIT for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly earnings before interest & taxes is -$3.70 M
What is Larimar Therapeutics quarterly EBIT year-on-year change?
Over the past year, LRMR quarterly earnings before interest & taxes has changed by +$6.33 M (+25.75%)
What is Larimar Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of LRMR is -$73.76 M
What is the all time high TTM EBIT for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM earnings before interest & taxes is -$3.70 M
What is Larimar Therapeutics TTM EBIT year-on-year change?
Over the past year, LRMR TTM earnings before interest & taxes has changed by -$7.92 M (-12.04%)